Mechanistic Studies of AVE3085 Against Homocysteine in Endothelial Protection

[1]  M. Underwood,et al.  AVE3085 Protects Coronary Endothelium from the Impairment of Asymmetric Dimethylarginine by Activation and Recoupling of eNOS , 2012, Cardiovascular Drugs and Therapy.

[2]  M. Underwood,et al.  TRPC3 channel contributes to nitric oxide release: significance during normoxia and hypoxia-reoxygenation. , 2011, Cardiovascular research.

[3]  M. Underwood,et al.  AVE3085, an enhancer of endothelial nitric oxide synthase, restores endothelial function and reduces blood pressure in spontaneously hypertensive rats , 2011, British journal of pharmacology.

[4]  Qin Yang,et al.  New Strategy of Endothelial Protection in Cardiac Surgery: Use of Enhancer of Endothelial Nitric Oxide Synthase , 2010, World Journal of Surgery.

[5]  A. Shoukas,et al.  Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats. , 2009, Journal of applied physiology.

[6]  C. Tschöpe,et al.  Enhancement of endothelial nitric oxide synthase production reverses vascular dysfunction and inflammation in the hindlimbs of a rat model of diabetes , 2008, Diabetologia.

[7]  P. Galuppo,et al.  Improvement in Left Ventricular Remodeling by the Endothelial Nitric Oxide Synthase Enhancer AVE9488 After Experimental Myocardial Infarction , 2008, Circulation.

[8]  U. Förstermann,et al.  Antiatherosclerotic Effects of Small-Molecular-Weight Compounds Enhancing Endothelial Nitric-Oxide Synthase (eNOS) Expression and Preventing eNOS Uncoupling , 2008, Journal of Pharmacology and Experimental Therapeutics.

[9]  A. Shoukas,et al.  Inducible NO Synthase–Dependent S-Nitrosylation and Activation of Arginase1 Contribute to Age-Related Endothelial Dysfunction , 2007, Circulation research.

[10]  C. Fang,et al.  Phytoestrogen α-zearalanol antagonizes homocysteine-induced imbalance of nitric oxide/endothelin-1 and apoptosis in human umbilical vein endothelial cells , 2007, Cell Biochemistry and Biophysics.

[11]  C. Heeschen,et al.  Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy , 2006, Proceedings of the National Academy of Sciences.

[12]  C. Fang,et al.  Phytoestrogen alpha-zearalanol antagonizes homocysteine-induced imbalance of nitric oxide/endothelin-1 and apoptosis in human umbilical vein endothelial cells. , 2006, Cell Biochemistry and Biophysics.

[13]  J. McNeill,et al.  Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes. , 2005, American journal of physiology. Heart and circulatory physiology.

[14]  A. Yim,et al.  Release of nitric oxide and endothelium-derived hyperpolarizing factor (EDHF) in porcine coronary arteries exposed to hyperkalemia: effect of nicorandil. , 2005, The Annals of thoracic surgery.

[15]  A. Lumsden,et al.  Ginsenoside Rb1 blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries. , 2005, Journal of vascular surgery.

[16]  A. Lumsden,et al.  Curcumin blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries. , 2004, Journal of vascular surgery.

[17]  S. Dalaklıoğlu,et al.  Poly(ADP-Ribose) Polymerase Inhibition Prevents Homocysteine-Induced Endothelial Dysfunction in the Isolated Rat Aorta , 2004, Pharmacology.

[18]  J. Boucher,et al.  Homocysteine induces oxidative stress by uncoupling of NO synthase activity through reduction of tetrahydrobiopterin. , 2004, Free radical biology & medicine.

[19]  A. Lumsden,et al.  Estrogen blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries(1,2). , 2004, The Journal of surgical research.

[20]  A. Lumsden,et al.  Red wine prevents homocysteine-induced endothelial dysfunction in porcine coronary arteries. , 2003, The Journal of surgical research.

[21]  J. Loscalzo,et al.  Homocysteine and atherothrombosis: Diagnosis and treatment , 2003, Current atherosclerosis reports.

[22]  Qin Yang,et al.  Bioassay of endothelium‐derived hyperpolarizing factor with abolishment of nitric oxide and the role of gap junctions in the porcine coronary circulation , 2003 .

[23]  A. Myers,et al.  Estradiol prevents homocysteine-induced endothelial injury in male rats. , 2002, Cardiovascular research.

[24]  B. Conklin,et al.  Homocysteine decreases endothelium-dependent vasorelaxation in porcine arteries. , 2002, The Journal of surgical research.

[25]  M. Goligorsky,et al.  Effects of homocysteine on endothelial nitric oxide production. , 2000, American journal of physiology. Renal physiology.

[26]  G. He,et al.  Endothelium-dependent hyperpolarization and relaxation resistance to N(G)-nitro-L-arginine and indomethacin in coronary circulation. , 2000, Cardiovascular research.

[27]  M. Lewis,et al.  Homocysteine-induced inhibition of endothelium-dependent relaxation in rabbit aorta: role for superoxide anions. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[28]  G. Hankey,et al.  Homocysteine and vascular disease , 1999, The Lancet.

[29]  D. Harrison,et al.  Validation of lucigenin as a chemiluminescent probe to monitor vascular superoxide as well as basal vascular nitric oxide production. , 1999, Biochemical and biophysical research communications.

[30]  K. Woo,et al.  Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans. , 1997, Circulation.

[31]  P. Vanhoutte,et al.  Bioassay of endothelium-derived hyperpolarizing factor. , 1996, Biochemical and biophysical research communications.

[32]  M. Modolell,et al.  Determination of arginase activity in macrophages: a micromethod. , 1994, Journal of immunological methods.